|
ISIN No
|
INE105J01010
|
BSE Code / NSE Code
|
532983 / RPGLIFE
|
Book Value (Rs.)
|
366.03
|
Face Value
|
8.00
|
|
Bookclosure
|
09/07/2026
|
52Week High
|
2994
|
EPS
|
69.64
|
P/E
|
41.96
|
|
Market Cap.
|
4832.53 Cr.
|
52Week Low
|
1733
|
P/BV / Div Yield (%)
|
7.98 / 0.82
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
The company history sections lists out major chronological events that happened to the company.
| 2009
- Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009.
2010
- Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company.
- Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company.
2011
- RPG Life Sciences launches dialysis deferring drug.
- Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company.
2012
-Board has recommended an equity dividend of Rs. 0.80 per share (10%).
2013
-RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility."
-RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore.
2014
-Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014.
2015
-RPG Life Plans Skincare Foray
2016
-RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry
-RPG Life gains over 14 pct on getting EUGMP certification
-RPG Life Sciences - RPG Life Sciences to expand its formulations business
2019
-RPG Life Sciences enters Anti-Diabetic therapeutic area.
|